PHASE-II EVALUATION OF 4'-(9-ACRIDINYLAMINO)-METHANESULFON-M-ANISIDINE (AMSA) IN PATIENTS WITH ADVANCED HEAD AND NECK CANCERS

被引：0
|
作者：
RATANATHARATHORN, V
DRELICHMAN, A
SEXONPORTE, M
ALSARRAF, M
机构：
[1] WAYNE STATE UNIV,SCH MED,DEPT ONCOL,DETROIT,MI 48201
[2] HARPER HOSP,DETROIT,MI 48201
[3] GRACE HOSP,DETROIT,MI 48201
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1982年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：29 / 32
页数：4
相关论文
共 50 条
  • [41] EVALUATION OF M-AMSA (NSC-249992) IN THE TREATMENT OF ADVANCED HEAD AND NECK-CANCER - PHASE-II STUDY
    RATANATHARATHORN, V
    YOSHIDA, S
    SEXONPORTE, M
    DRELICHMAN, A
    ALSARRAF, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 526 - 526
  • [42] PHASE-II TRIAL OF AMSA (4'-9(ACRIDINYLAMINO)-METHANE-SULFON-M-ANISIDIDE) IN PRIMARY LIVER-CANCER
    LIGHTDALE, C
    CHENG, E
    FORTNER, J
    YOUNG, C
    GOLBEY, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 417 - 417
  • [43] 4’-(9-Acridinylamino)Methanesulfon-m-Anisidide(AMSA)——一种治疗成人急性白血病有效的新药
    卢昌沅
    国外医学输血及血液学分册., 1981, (04) : 253 - 254
  • [44] HYDROXYUREA POTENTIATION OF THE ANTINEOPLASTIC ACTIVITY OF CYCLOPHOSPHAMIDE AND 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (AMSA) IN THE BROWN NORWAY RAT MYELOCYTIC-LEUKEMIA MODEL
    VAUGHAN, WP
    HOLM, C
    CORDEL, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (01) : 26 - 30
  • [45] PHASE-II STUDY WITH ESORUBICIN (DXDX) IN PATIENTS WITH ADVANCED HEAD AND NECK CANCERS (CTC)
    GASPARINI, G
    FRUSTACI, S
    MAGRI, MD
    VERONESI, A
    CRIVELLARI, D
    TIRELLI, U
    BARZAN, L
    MONFARDINI, S
    TUMORI, 1986, 72 (06) : 710 - 710
  • [46] PHASE-II EVALUATION OF MAYTANSINE IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER
    CREAGAN, ET
    FLEMING, TR
    EDMONSON, JH
    INGLE, JN
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2061 - 2062
  • [47] PHASE-II EVALUATION OF PALA IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER
    CREAGAN, ET
    NICHOLS, WC
    OFALLON, JR
    CANCER TREATMENT REPORTS, 1981, 65 (9-10): : 827 - 829
  • [48] EARLY CLINICAL EVALUATION OF ACRIDINYLAMINO-METHANESULFON-M-ANISIDIDE (AMSA) IN PATIENTS WITH ADVANCED BREAST-CANCER AND ACUTE-LEUKEMIA
    LEGHA, SS
    BODEY, GP
    KEATING, MJ
    BLUMENSCHEIN, GR
    HORTOBAGYI, GN
    BUZDAR, AU
    MCCREDIE, K
    FREIREICH, EJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 416 - 416
  • [49] PHASE-II EVALUATION OF DIANHYDROGALACTITOL IN ADVANCED HEAD AND NECK CARCINOMAS
    EDMONSON, JH
    FRYTAK, S
    LETENDRE, L
    KVOLS, LK
    EAGAN, RT
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2081 - 2083
  • [50] ECHOCARDIOGRAPHIC AND ECG ABNORMALITIES IN PEDIATRIC-PATIENTS RECEIVING 4'-(9-ACRIDINYLAMINO)-METHANE SULFON-M-ANISIDIDE (AMSA)
    STEINHERZ, L
    MANGIACASALE, D
    STEINHERZ, P
    TAN, C
    MILLER, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 143 - 143
12345